Phase II study of accelerated Linac-based SBRT in five consecutive fractions for localized prostate cancer
ConclusionsAccelerated SBRT for low-intermediate PC is feasible and well tolerated with comparable oncological outcome as described for other series with the same RT technique but treatment delivery on every other day. Longer follow-up is needed to the assess late toxicity profile and long-term clinical outcome.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Medical Ethics | Prostate Cancer | Radiation Therapy | Study | Toxicology